Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Harmaline, also known as 7-methoxyharmalan or as 3,4-dihydro-7-methoxy-1-methyl-β-carboline, is a harmala alkaloid and β-carboline which has hallucinogenic effects and monoamine oxidase inhibitor (MAOI) activity. It is the partly hydrogenated form of harmine.
History, Applications & Art
Explore the main themes, entities and connections around Harmaline. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
harmala effects alkaloids also ibogaine hallucinogenic harmine plants monoamine oxidase schedule serotonin orally syrian rue duration dmt humans first chemical
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Harmaline | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Harmaline | ATC code | None | 1.00 | infobox |
| Harmaline | CAS Number | 304-21-2 Y | 1.00 | infobox |
| Harmaline | ChEBI | CHEBI:28172 Y | 1.00 | infobox |
| Harmaline | ChEMBL | ChEMBL340807 Y | 1.00 | infobox |
| Harmaline | ChemSpider | 10211258 Y | 1.00 | infobox |
| Harmaline | CompTox Dashboard (EPA) | DTXSID8041038 | 1.00 | infobox |
| Harmaline | Drug class | Hallucinogen; Oneirogen; Monoamine oxidase inhibitor; Reversible inhibitor of MAO-A | 1.00 | infobox |
| Harmaline | Duration of action | Oral: 5–8 hours IV: "Much shorter" (than oral) | 1.00 | infobox |
| Harmaline | ECHA InfoCard | 100.005.594 | 1.00 | infobox |
| Harmaline | Elimination half-life | 2 hours | 1.00 | infobox |
| Harmaline | Formula | C13H14N2O | 1.00 | infobox |
| Harmaline | KEGG | C06536 Y | 1.00 | infobox |
| Harmaline | Legal status | AU: S9 (Prohibited substance) | 1.00 | infobox |
| Harmaline | Legal status | CA: Schedule III | 1.00 | infobox |
| Harmaline | Melting point | 232 to 234 °C (450 to 453 °F) | 1.00 | infobox |
| Harmaline | Molar mass | 214.268 g·mol−1 | 1.00 | infobox |
| Harmaline | Onset of action | Oral: 1–2 hours IVTooltip Intravenous injection: Seconds | 1.00 | infobox |
| Harmaline | Other names | 7-Methoxyharmalan; 7-MeO-harmalan; 7-OMe-harmalan; 7-Methoxy-3,4-dihydroharman; 3,4-Dihydroharmine; 3,4-Dihydro-7-methoxy-1-methyl-β-carboline; Harmadine | 1.00 | infobox |
| Harmaline | PubChem CID | 5280951 | 1.00 | infobox |
| Harmaline | Routes of administration | Oral, intravenous | 1.00 | infobox |
| Harmaline | UNII | CN58I4TOET | 1.00 | infobox |
| Harmaline | is a | only harmala alkaloid that has a reputation of being hallucinogenic | 0.90 | text |
| Harmaline | is a | RIMA | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.